Ariel Berger

Summary

Affiliation: Policy Analysis Inc
Country: USA

Publications

  1. pmc Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, PAI, 4 Davis Court, Brookline, MA 02445, USA
    BMC Pulm Med 12:75. 2012
  2. pmc Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, PAI, Brookline, MA, USA
    BMC Psychiatry 12:177. 2012
  3. pmc Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc PAI, Four Davis Court, Brookline, MA 02445, USA
    BMC Psychiatry 12:99. 2012
  4. doi request reprint Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapy
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445, USA
    Clin Ther 34:1350-63. 2012
  5. pmc Resource utilization and costs before and after total joint arthroplasty
    Kevin J Bozic
    University of California, San Francisco, Department of Orthopaedic Surgery, San Francisco, CA 94143 0728, USA
    BMC Health Serv Res 12:73. 2012
  6. doi request reprint Direct and indirect economic costs among private-sector employees with osteoarthritis
    Ariel Berger
    Policy Analysis, Inc, Brookline, MA 02445, USA
    J Occup Environ Med 53:1228-35. 2011
  7. pmc Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder
    Ariel Berger
    Policy Analysis, Inc, Brookline, USA
    BMC Geriatr 9:31. 2009
  8. doi request reprint Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis
    Ariel Berger
    Policy Analysis, Inc, Brookline, Massachusetts 02445, USA
    Arthritis Rheum 63:2268-75. 2011
  9. pmc Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, Four Davis Court, Brookline, MA, 02445, USA
    BMC Psychiatry 11:193. 2011
  10. ncbi request reprint Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia
    Ariel Berger
    Policy Analysis Inc, Four Davis Ct, Brookline, MA 02445, USA
    Am J Manag Care 16:S126-37. 2010

Detail Information

Publications35

  1. pmc Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, PAI, 4 Davis Court, Brookline, MA 02445, USA
    BMC Pulm Med 12:75. 2012
    ..Little is known concerning the degree to which initiation of sildenafil for pulmonary arterial hypertension (PAH) impacts patterns of healthcare utilization and costs...
  2. pmc Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, PAI, Brookline, MA, USA
    BMC Psychiatry 12:177. 2012
    ..While benzodiazepines typically provide rapid symptomatic relief, long-term use is not recommended due to risks of dependency, sedation, falls, and accidents...
  3. pmc Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc PAI, Four Davis Court, Brookline, MA 02445, USA
    BMC Psychiatry 12:99. 2012
    ..While patients who are hospitalized for schizophrenia and bipolar disorder often receive these agents at discharge, comparatively little information exists on subsequent patterns of pharmacotherapy...
  4. doi request reprint Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapy
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445, USA
    Clin Ther 34:1350-63. 2012
    ..Previous studies of the use of erythropoiesis-stimulating agents (ESAs) in patients with anemia concomitant with chemotherapy may thus not reflect current clinical practice...
  5. pmc Resource utilization and costs before and after total joint arthroplasty
    Kevin J Bozic
    University of California, San Francisco, Department of Orthopaedic Surgery, San Francisco, CA 94143 0728, USA
    BMC Health Serv Res 12:73. 2012
    ..The purpose of this study was to compare pre- and post-surgical healthcare costs in commercially insured total joint arthroplasty (TJA) patients with osteoarthritis (OA) in the United States (U.S.)...
  6. doi request reprint Direct and indirect economic costs among private-sector employees with osteoarthritis
    Ariel Berger
    Policy Analysis, Inc, Brookline, MA 02445, USA
    J Occup Environ Med 53:1228-35. 2011
    ..To estimate direct and indirect economic costs among private-sector employees with osteoarthritis (OA)...
  7. pmc Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder
    Ariel Berger
    Policy Analysis, Inc, Brookline, USA
    BMC Geriatr 9:31. 2009
    ..The actual extent of use of these agents in clinical practice is unknown, however...
  8. doi request reprint Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis
    Ariel Berger
    Policy Analysis, Inc, Brookline, Massachusetts 02445, USA
    Arthritis Rheum 63:2268-75. 2011
    ..To examine patterns of pharmacotherapy and health care utilization and costs prior to total knee replacement (TKR) or total hip replacement (THR) in patients with osteoarthritis (OA)...
  9. pmc Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, Four Davis Court, Brookline, MA, 02445, USA
    BMC Psychiatry 11:193. 2011
    ..Patterns of healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder (GAD) have not been well characterized...
  10. ncbi request reprint Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia
    Ariel Berger
    Policy Analysis Inc, Four Davis Ct, Brookline, MA 02445, USA
    Am J Manag Care 16:S126-37. 2010
    ..To compare healthcare utilization and costs in the year preceding and following initial diagnosis of fibromyalgia (FM)...
  11. ncbi request reprint Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders
    Gerry Oster
    Policy Analysis, Inc, Brookline, Massachusetts 02445, USA
    Am J Geriatr Pharmacother 2:163-70. 2004
    ..Although older adults with painful neuropathic disorders (PNDs) would appear to be at elevated risk for receiving potentially inappropriate pain-related medications, the extent of such drug use in this population is unknown...
  12. pmc Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445, USA
    BMC Neurol 12:8. 2012
    ..Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders (PNDs) who are under the care of general practitioners (GPs) in the UK are not well understood...
  13. ncbi request reprint Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany
    Ariel Berger
    Policy Analysis, Inc, Brookline, MA 02445, USA
    Curr Med Res Opin 24:2489-99. 2008
    ..To examine characteristics and patterns of healthcare utilization of patients with fibromyalgia (FM) under the care of general practitioners (GPs) in Germany...
  14. doi request reprint Clinical and economic characteristics of patients with painful neuropathic disorders in Germany
    Ariel Berger
    Policy Analysis Inc PAI, Brookline, Massachusetts 02445, USA
    Pain Pract 9:8-17. 2009
    ..The pain-related medications that these patients receive raise concerns that PNDs may not be optimally treated in these settings...
  15. ncbi request reprint Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease
    Ariel Berger
    Policy Analysis, Inc, Four Davis Ct, Brookline, MA 02445, USA
    Am J Manag Care 15:509-18. 2009
    ..To compare healthcare utilization and costs in patients with end-stage renal disease (ESRD) beginning peritoneal dialysis (PD) or hemodialysis (HD)...
  16. doi request reprint Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Clin Ther 30:206-18. 2008
    ..DA and EA differ, however, with respect to their assumed duration of effect and thus their approved frequency of dosing, complicating direct comparison of their doses and costs...
  17. ncbi request reprint Economic impact of shifting the locus of care for neuropathic pain from specialists to general practitioners
    Ariel Berger
    Policy Analysis, Inc, Four Davis Court, Brookline, MA 02445, USA
    Eur J Health Econ 8:245-51. 2007
    ..1 million NOK (approx. US $11.9 million). A partial shift in the locus of care of painful neuropathies from specialists to GPs may result in substantial cost savings to the Norwegian health-care system...
  18. ncbi request reprint Opioid use and health care charges at the end of life in patients with metastatic cancer
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Manag Care Interface 17:28-34. 2004
    ..Patients receiving TF started LAO therapy closer to their date of death, and had significantly higher hospitalization charges than did patients receiving CRO and CRM...
  19. doi request reprint Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K
    Ariel Berger
    Policy Analysis Inc PAI, Brookline, Massachusetts 02445, USA
    Pain Pract 9:18-34. 2009
    ..To examine the use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners (GPs) in the U.K...
  20. doi request reprint Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections
    John Edelsberg
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Surg Infect (Larchmt) 9:335-47. 2008
    ..Initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infection (cIAI) usually is empiric. We explored the economic consequences of failure of such therapy in this patient population...
  21. ncbi request reprint Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy
    Ariel Berger
    Policy Analysis, Inc PAI, Brookline, MA, USA
    Clin J Pain 23:251-8. 2007
    ..To describe patterns of use of tricyclic antidepressants (TCAs) (eg, amitriptyline, nortriptyline) among older patients with diabetic peripheral neuropathy (DPN)...
  22. doi request reprint Identification of patients receiving peritoneal dialysis using health insurance claims data
    Ariel Berger
    Policy Analysis, Inc, Brookline, Massachusetts 02445, USA
    Clin Ther 31:1321-34. 2009
    ..The aim of this analysis was to assess alternative methods of identification of patients treated with peritoneal dialysis (PD) in health care claims databases for possible use in future analyses of costs of this treatment modality...
  23. ncbi request reprint Clinical characteristics and economic costs of patients with painful neuropathic disorders
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    J Pain 5:143-9. 2004
    ..Our study raises questions about the optimality of PND treatment in clinical practice...
  24. ncbi request reprint Therapy switching in patients receiving long-acting opioids
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445 7629, USA
    Ann Pharmacother 38:389-95. 2004
    ..Patterns of therapy switching in patients receiving long-acting opioids have not been well documented...
  25. doi request reprint Clinically based surveillance of invasive meningococcal disease in young children admitted to selected US hospitals between January 2000 and June 2009: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, Brookline, MA, USA
    Hum Vaccin Immunother 8:384-9. 2012
    ....
  26. ncbi request reprint Dose intensification with infliximab in patients with rheumatoid arthritis
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445, USA
    Ann Pharmacother 39:2021-5. 2005
    ....
  27. ncbi request reprint Economic consequences of venous thromboembolism following major orthopedic surgery
    Gerry Oster
    Policy Analysis Inc, Brookline, MA 02445 7629, USA
    Ann Pharmacother 38:377-82. 2004
    ..Venous thromboembolism (VTE) is a frequent and potentially costly complication of major orthopedic surgery...
  28. ncbi request reprint Use of tricyclic antidepressants in older patients with painful neuropathies
    Ariel Berger
    Policy Analysis Inc PAI, Four Davis Court, Brookline, MA 02445, USA
    Eur J Clin Pharmacol 62:757-64. 2006
    ..To describe patterns of use of tricyclic antidepressants (TCAs) (e.g., amitriptyline, nortriptyline) in older patients with painful neuropathies...
  29. doi request reprint Initial treatment failure in patients with complicated skin and skin structure infections
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Surg Infect (Larchmt) 14:304-12. 2013
    ..Consequences of initial antibiotic failure in patients hospitalized for complicated skin and skin-structure infections (cSSSI) are not well understood...
  30. doi request reprint Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortality
    Gerry Oster
    Policy Analysis Inc PAI, Brookline, MA 02445, USA
    J Med Econ 16:809-19. 2013
    ....
  31. ncbi request reprint Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitis
    Charu Taneja
    Policy Analysis Inc PAI, Brookline, MA 02445, USA
    J Drugs Dermatol 9:372-6. 2010
    ..Tacrolimus 0.1% and pimecrolimus 1.0% are used for short-term and noncontinuous treatment of atopic dermatitis (AD) in patients unresponsive to conventional therapies...
  32. doi request reprint Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections
    John Edelsberg
    Policy Analysis, Brookline, Massachusetts 02445, USA
    Infect Control Hosp Epidemiol 29:160-9. 2008
    ..To estimate the consequences of failure of initial antibiotic therapy for patients with complicated skin and skin-structure infections...
  33. doi request reprint Adherence with migraine prophylaxis in clinical practice
    Ariel Berger
    Policy Analysis, Inc PAI, Brookline, Massachusetts, USA
    Pain Pract 12:541-9. 2012
    ..To characterize adherence with antidepressants, antiepileptic drugs, and beta blockers as prophylaxis against migraine in typical clinical practice...
  34. ncbi request reprint Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Clin Ther 25:2809-21. 2003
    ..Although opioids are sometimes effective for chronic neuropathic pain, adverse effects are common, particularly among the elderly, and may cause many patients to discontinue therapy...
  35. ncbi request reprint Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    J Pain Symptom Manage 26:723-30. 2003
    ..8% and 31.3%, and 28.7% and 13.1%. These relatively low rates of opioid use among patients with metastatic cancer in their final year of life suggest that pain in many cases may be suboptimally treated...